Welcome to CDC stacks | Clinical Chemistry and Dried Blood Spots: Increasing Laboratory Utilization by Improved Understanding of Quantitative Challenges - 32711 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clinical Chemistry and Dried Blood Spots: Increasing Laboratory Utilization by Improved Understanding of Quantitative Challenges
Filetype[PDF-50.52 KB]


No Related Documents.
You May Also Like:
  1. Succinylacetone as Primary Marker to Detect Tyrosinemia Type I in Newborns and its Measurement by Newborn Screening Programs
    Personal Author:
    De Jesús, Víctor R.; Adam, Barbara W.; Mandel, Daniel; Cuthbert, Carla D.; Matern, Dietrich;
    Published:
    2014 Sep-Oct
    Source:
    Mol Genet Metab. 113(0):67-75.
    Description:
    Tyrosinemia type I (TYR I) is caused by autosomal recessive fumarylacetoacetate hydrolase deficiency and is characterized by development of severe liver disease in infancy and neurologic crises. If left untreated, most patients die of liver failure i...
    File Type:
    Filetype[PDF - 592.05 KB]
  2. Bridging the Gap between Sample Collection and Laboratory Analysis: Using Dried Blood Spots to Identify Human Exposure to Chemical Agents
    Personal Author:
    Hamelin, Elizabeth I.; Blake, Thomas A.; Perez, Jonas W.; Crow, Brian S.; Shaner, Rebecca L.; Coleman, Rebecca M.; Johnson, Rudolph C.;
    Published:
    May 13 2016
    Source:
    Proc SPIE Int Soc Opt Eng. 98630:98630P-98630P-9.
    Description:
    Public health response to large scale chemical emergencies presents logistical challenges for sample collection, transport, and analysis. Diagnostic methods used to identify and determine exposure to chemical warfare agents, toxins, and poisons tradi...
    File Type:
    Filetype[PDF - 378.53 KB]
  3. Using tandem mass spectrometry for metabolic disease screening among newborns; a report of a Work Group
    Personal Author:
    Grosse, Scott D.; Hannon, W. Harry;
    Corporate Author:
    National Center for Environmental Health (U.S.). Centers for Disease Control and Prevention (U.S.). National Newborn Screening & Genetics Resource Center (U.S.).
    Published:
    April 13, 2001
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 50, no. RR-3
    Description:
    Increasingly, tandem mass spectrometry (MS/MS) is being used for newborn screening because this laboratory testing technology substantially increases the number of metabolic disorders that can be detected from dried blood-spot specimens. In June 2000...
    File Type:
    Filetype[PDF - 285.84 KB]
  4. Investigation of dried blood sampling with liquid chromatography tandem mass spectrometry to confirm human exposure to nerve agents
    Personal Author:
    Shaner, Rebecca L.; Coleman, Rebecca M.; Schulze, Nicholas; Platanitis, Kelsey; Brown, Ashli A.; Seymour, Craig; Kaplan, Pearl; Perez, Jonas; Hamelin, Elizabeth I.; Johnson, Rudolph C.;
    Published:
    June 20 2018
    Source:
    Anal Chim Acta. 1033:100-107
    Description:
    A method was developed to detect and quantify organophosphate nerve agent (OPNA) metabolites in dried blood samples. Dried blood spots (DBS) and microsampling devices are alternatives to traditional blood draws, allowing for safe handling, extended s...
    File Type:
    Filetype[PDF - 867.77 KB]
  5. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders
    Personal Author:
    Chen, Bin; Mei, Joanne; Kalman, Lisa; Shahangian, Shahram; Williams, Irene; Gagnon, MariBeth; Bosse, Diane; Ragin, Angela; Cuthbert, Carla; Zehnbauer, Barbara;
    Corporate Author:
    National Center for Environmental Health (U.S.). Division of Laboratory Sciences.. Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology, and Laboratory Services. Division of Laboratory Science and Standards.. National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health..
    Published:
    April 6, 2012
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 61, no. 2
    Description:
    Biochemical genetic testing and newborn screening are essential laboratory services for the screening, detection, diagnosis, and monitoring of inborn errors of metabolism or inherited metabolic disorders. Under the Clinical Laboratory Improvement Ame...
    Status:
    current
    File Type:
    Filetype[PDF - 891.33 KB]